Get the Stockscreener App
47.04
0.73%
0.34
After Hours:
47.04
Qiagen Nv stock is traded at $47.04, with a volume of 835.60K.
It is up +0.73% in the last 24 hours and down -6.39% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
See More
Previous Close:
$46.70
Open:
$46.55
24h Volume:
835.60K
Relative Volume:
0.59
Market Cap:
$10.17B
Revenue:
$1.98B
Net Income/Loss:
$83.59M
P/E Ratio:
125.78
EPS:
0.374
Net Cash Flow:
$502.31M
1W Performance:
+1.95%
1M Performance:
-6.39%
6M Performance:
+24.38%
1Y Performance:
+3.56%
1-Day Range:
$46.27
$47.07
1-Week Range:
$46.08
$47.38
52-Week Range:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
47.04 | 10.17B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
489.49 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.03 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.44 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
128.48 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
184.08 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-04-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-06-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
What analysts say about Qiagen N.V. stock2025 Macro Impact & Free Real-Time Market Sentiment Alerts - khodrobank.com
Investors in Qiagen (NYSE:QGEN) have unfortunately lost 4.9% over the last five years - Yahoo Finance
Chart based analysis of Qiagen N.V. trendsWeekly Risk Summary & Daily Technical Forecast Reports - Newser
Will Qiagen N.V. outperform the market2025 Market Trends & Long Hold Capital Preservation Plans - Newser
Real time social sentiment graph for Qiagen N.V.Buy Signal & Momentum Based Trading Ideas - Newser
Does Qiagen N.V. meet Warren Buffett’s criteria2025 Geopolitical Influence & Verified Short-Term Plans - khodrobank.com
Long term hold vs stop loss in Qiagen N.V.Weekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Will Qiagen N.V. stock go up soonWeekly Trend Recap & Stock Portfolio Risk Control - Newser
Can swing trading help recover from Qiagen N.V. lossesWeekly Stock Summary & Community Consensus Stock Picks - Newser
Is Qiagen N.V. stock a good dividend stockPortfolio Profit Report & Long-Term Safe Investment Ideas - khodrobank.com
Is Qiagen N.V. stock showing strong momentumJuly 2025 Review & Low Risk High Reward Trade Ideas - khodrobank.com
Analyzing recovery setups for Qiagen N.V. investorsTrade Volume Summary & Daily Stock Trend Watchlist - Newser
Qiagen N.V. stock prediction for this weekWeekly Trade Recap & Fast Gain Swing Alerts - Newser
Multi asset correlation models including Qiagen N.V.Earnings Beat & Technical Buy Zone Confirmation - Newser
QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise - TradingView
Is Qiagen N.V. still worth holding after the dip2025 Technical Patterns & Safe Entry Momentum Stock Tips - Newser
When is the best time to exit Qiagen N.V.2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Earnings visualization tools for Qiagen N.V.Portfolio Gains Report & Long Hold Capital Preservation Plans - Newser
What’s next for Qiagen N.V. stockJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - khodrobank.com
Can Qiagen N.V. expand into new marketsJuly 2025 Fed Impact & Verified Stock Trade Ideas - khodrobank.com
Is now a turning point for Qiagen N.V.Fed Meeting & Accurate Entry/Exit Alerts - Newser
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing - sharewise.com
Qiagen N.V.’s volatility index tracking explainedWeekly Trend Recap & Smart Money Movement Tracker - Newser
Qiagen’s Voting Rights Announcement Involves BlackRock’s Significant Holdings - MSN
Qiagen's (NYSE:QGEN) Strong Earnings Are Of Good Quality - simplywall.st
Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others - Yahoo Eurosport UK
Qiagen shares rise 1.53% premarket after FDA clearance of higher-throughput QIAstat-Dx Rise system. - AInvest
Is Qiagen N.V. forming a bullish divergenceM&A Rumor & Smart Allocation Stock Reports - khodrobank.com
QIAGEN N.V. Launches QIAstat-Dx Rise, a High-Throughput Automated Syndromic Testing System with FDA Clearance. - AInvest
How does Qiagen N.V. score in quality rankings2025 Top Decliners & Long-Term Safe Return Strategies - khodrobank.com
How to escape a deep drawdown in Qiagen N.V.July 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
QIAGEN receives FDA clearance for higher-throughput diagnostic system - StreetInsider
Qiagen Says US FDA Clears Syndromic Testing System - 富途牛牛
US FDA Clears Qiagen's Syndromic Testing System - AInvest
Qiagen Gains US Clearance for Higher-Throughput QIAstat-Dx Rise - AInvest
QIAGEN Introduces QIAstat-Dx Rise: A Higher-Throughput Automated Syndromic Testing System Cleared by FDA. - AInvest
Qiagen gains U.S. clearance of higher-throughput QIAstat-Dx Rise - MarketScreener
160 Tests Per Day: QIAGEN's New QIAstat-Dx Rise System Receives FDA Clearance for Rapid Diagnostics - Stock Titan
Is Qiagen N.V. currently under institutional pressureWeekly Profit Analysis & Technical Entry and Exit Alerts - khodrobank.com
Does Qiagen N.V. have a sustainable dividend2025 Trading Volume Trends & AI Driven Price Predictions - khodrobank.com
Real time pattern detection on Qiagen N.V. stockJuly 2025 Sentiment & Verified Momentum Watchlists - Newser
Qiagen grabbed 'opportunistic window' to sell $750m CB - GlobalCapital
Can Qiagen N.V. be the next market leaderJuly 2025 Update & Daily Growth Stock Tips - khodrobank.com
Sentiment analysis tools applied to Qiagen N.V.2025 Year in Review & Verified Chart Pattern Signals - Newser
Trend Dashboard Flags Qiagen N.V. As Potential Swing Trade getLinesFromResByArray error: size == 0 - 강소기업뉴스
What Fibonacci levels say about Qiagen N.V. reboundSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Qiagen N.V. stock trend forecastWeekly Trend Summary & Safe Capital Investment Plans - Newser
Does Qiagen N.V. qualify in momentum factor screeningBond Market & Long-Term Safe Investment Plans - Newser
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.32%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):